Apraxia screening predicts Alzheimer pathology in frontotemporal dementia. [electronic resource]
- Journal of neurology, neurosurgery, and psychiatry 05 2019
- 562-569 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1468-330X
10.1136/jnnp-2018-318470 doi
Aged Aged, 80 and over Alzheimer Disease--complications Amyloid beta-Peptides Apraxias--diagnosis Biomarkers--cerebrospinal fluid Cohort Studies Female Frontotemporal Dementia--complications Humans Male Middle Aged Sensitivity and Specificity tau Proteins--cerebrospinal fluid